HOOK RSI Chart
Last 7 days
6.5%
Last 30 days
7.9%
Last 90 days
24.2%
Trailing 12 Months
-39.3%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 53.6M | 0 | 0 | 0 |
2023 | 16.0M | 15.9M | 20.6M | 20.1M |
2022 | 14.6M | 12.0M | 10.3M | 14.2M |
2021 | 21.2M | 19.9M | 19.7M | 18.4M |
2020 | 13.4M | 16.0M | 18.0M | 19.6M |
2019 | 9.9M | 13.3M | 13.4M | 11.9M |
2018 | 0 | 0 | 0 | 7.6M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Aug 21, 2023 | kandera reinhard | bought | 5,075 | 0.725 | 7,000 | chief financial officer |
Aug 16, 2023 | kandera reinhard | bought | 5,712 | 0.714 | 8,000 | chief financial officer |
Jul 11, 2023 | aldag jorn | bought | 4,142 | 0.8284 | 5,000 | chief executive officer |
Jul 07, 2023 | aldag jorn | bought | 4,050 | 0.81 | 5,000 | chief executive officer |
Jul 05, 2023 | aldag jorn | bought | 4,450 | 0.89 | 5,000 | chief executive officer |
Jul 03, 2023 | aldag jorn | bought | 4,455 | 0.8911 | 5,000 | chief executive officer |
Jun 30, 2023 | kandera reinhard | bought | 10,560 | 0.88 | 12,000 | chief financial officer |
Feb 01, 2022 | necina roman | acquired | 38,676 | 3.00 | 12,892 | chief technology officer |
Feb 01, 2022 | baker christine d. | acquired | 40,974 | 3.00 | 13,658 | chief business officer |
Feb 01, 2022 | kandera reinhard | acquired | 42,168 | 3.00 | 14,056 | chief financial officer |
Which funds bought or sold HOOK recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 17, 2024 | Artal Group S.A. | unchanged | - | -555,516 | 4,034,480 | 0.10% |
May 17, 2024 | Ikarian Capital, LLC | unchanged | - | -52,016 | 377,913 | 0.04% |
May 16, 2024 | JANE STREET GROUP, LLC | new | - | 18,514 | 18,514 | -% |
May 15, 2024 | TWO SIGMA ADVISERS, LP | new | - | 25,347 | 25,347 | -% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | sold off | -100 | -66,534 | - | -% |
May 15, 2024 | Redmile Group, LLC | unchanged | - | -104,249 | 757,404 | 0.03% |
May 15, 2024 | Knoll Capital Management, LLC | unchanged | - | -540,703 | 3,928,380 | 2.44% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | reduced | -28.56 | -17,369 | 29,315 | -% |
May 15, 2024 | BAKER BROS. ADVISORS LP | unchanged | - | -796,558 | 5,787,240 | 0.07% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | added | 491 | 54,495 | 67,468 | -% |
Unveiling Hookipa Pharma Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Hookipa Pharma Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 394.1% | 36,599,000 | 7,407,000 | 6,867,000 | 2,679,000 | 3,176,000 | 7,828,000 | 2,230,000 | 2,746,000 | 1,445,000 | 3,895,000 | 3,874,000 | 5,378,000 | 5,301,000 | 5,163,000 | 4,040,000 | 6,685,000 | 3,696,000 | 3,618,000 | 2,038,000 | 4,051,000 | 2,235,000 |
Costs and Expenses | -33.4% | 25,493,000 | 38,302,000 | 29,537,000 | 24,151,000 | 25,833,000 | 21,416,000 | 23,223,000 | 21,173,000 | 21,592,000 | 25,942,000 | 25,040,000 | 24,667,000 | 24,473,000 | 20,357,000 | 20,446,000 | 15,911,000 | 16,155,000 | 16,843,000 | 15,614,000 | 17,680,000 | 12,890,000 |
Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17,680,000 | 12,890,000 |
S&GA Expenses | -100.0% | - | 4,374,000 | 4,912,000 | 4,445,000 | 4,902,000 | 3,824,000 | 4,937,000 | 5,026,000 | 4,972,000 | 3,523,000 | 4,342,000 | 5,095,000 | 4,309,000 | 4,669,000 | 4,437,000 | 4,347,000 | 4,629,000 | 5,664,000 | 4,589,000 | 3,751,000 | 2,711,000 |
R&D Expenses | -4.7% | 20,168,000 | 21,162,000 | 24,625,000 | 19,706,000 | 20,931,000 | 17,592,000 | 18,286,000 | 16,147,000 | 16,620,000 | 22,419,000 | 20,698,000 | 19,572,000 | 20,164,000 | 15,688,000 | 16,009,000 | 11,564,000 | 11,526,000 | 11,179,000 | 11,025,000 | 13,929,000 | 10,179,000 |
EBITDA Margin | 78.7% | -0.82 | -3.84 | -3.17 | -4.02 | -3.89 | -4.24 | -6.70 | -5.89 | -4.86 | -3.80 | -3.12 | -2.77 | -2.14 | -2.00 | -2.00 | -2.16 | -2.99 | -3.27 | -2.43 | -1.91 | -1.97 |
Interest Expenses | -95.9% | 2,000 | 49,000 | 49,000 | 97,000 | 122,000 | 108,000 | 105,000 | 231,000 | 243,000 | 227,000 | 234,000 | 218,000 | 219,000 | 199,000 | 194,000 | 166,000 | 227,000 | 227,000 | 227,000 | 210,000 | 213,000 |
Income Taxes | -100.0% | - | 163,500 | - | - | 205,000 | 229,000 | - | 1,000 | - | - | 1,000 | - | - | - | - | - | - | -109,000 | 9,000 | 100,000 | - |
Earnings Before Taxes | 158.3% | 14,383,000 | -24,654,500 | -19,066,000 | -18,016,000 | -19,475,000 | -12,082,000 | -18,280,000 | -16,355,000 | -17,968,000 | -21,234,500 | -20,039,000 | -17,153,000 | -17,238,000 | -12,474,500 | -13,589,000 | -7,092,000 | -10,926,000 | -10,353,000 | -11,376,000 | -11,979,000 | -9,329,000 |
EBT Margin | 78.1% | -0.88 | -4.03 | -3.34 | -4.26 | -4.14 | -4.54 | -7.16 | -6.32 | -5.24 | -4.10 | -3.39 | -3.04 | -2.38 | -2.25 | -2.33 | -2.48 | -3.33 | -3.60 | -2.58 | -2.05 | -2.13 |
Net Income | 158.0% | 14,400,000 | -24,818,000 | -19,066,000 | -18,016,000 | -19,680,000 | -12,311,000 | -18,280,000 | -16,356,000 | -17,968,000 | -21,234,500 | -20,040,000 | -17,153,000 | -17,238,000 | -12,475,000 | -13,589,000 | -7,092,000 | -10,926,000 | -10,244,000 | -11,385,000 | -12,079,000 | -9,329,000 |
Net Income Margin | 78.1% | -0.89 | -4.05 | -3.36 | -4.29 | -4.17 | -4.56 | -7.16 | -6.32 | -5.24 | -4.10 | -3.39 | -3.04 | -2.38 | -2.25 | -2.32 | -2.47 | -3.33 | -3.60 | -2.59 | -2.05 | -2.13 |
Free Cashflow | -108.4% | -24,272,000 | -11,646,000 | -27,137,000 | -19,778,000 | -3,122,000 | 12,538,000 | -17,466,000 | -19,991,000 | -95,000 | -18,384,000 | -20,130,000 | -25,356,000 | -14,727,000 | -11,806,000 | -10,990,000 | -11,587,000 | -7,327,000 | -9,839,000 | -9,847,000 | -11,588,000 | -12,456,000 |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -9.6% | 146 | 161 | 164 | 191 | 163 | 170 | 152 | 172 | 196 | 126 | 142 | 166 | 170 | 188 | 121 | 133 | 136 | 144 | 152 | 168 | 102 |
Current Assets | -9.8% | 133 | 147 | 139 | 168 | 140 | 147 | 130 | 149 | 171 | 102 | 119 | 143 | 153 | 172 | 106 | 118 | 121 | 128 | 136 | 151 | 85.00 |
Cash Equivalents | -20.6% | 93.00 | 117 | 108 | 136 | 110 | 112 | 101 | 119 | 142 | 67.00 | 83.00 | 103 | 128 | 143 | 82.00 | 93.00 | 105 | 114 | 124 | 135 | 71.00 |
Net PPE | -5.3% | 7.00 | 8.00 | 20.00 | 18.00 | 18.00 | 18.00 | 17.00 | 17.00 | 17.00 | 16.00 | 15.00 | 13.00 | 6.00 | 6.00 | 6.00 | 6.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Liabilities | -42.2% | 41.00 | 71.00 | 69.00 | 79.00 | 80.00 | 68.00 | 38.00 | 40.00 | 48.00 | 36.00 | 34.00 | 40.00 | 30.00 | 32.00 | 29.00 | 29.00 | 27.00 | 26.00 | 26.00 | 32.00 | 30.00 |
Current Liabilities | -29.7% | 30.00 | 42.00 | 41.00 | 46.00 | 44.00 | 36.00 | 26.00 | 27.00 | 31.00 | 28.00 | 27.00 | 34.00 | 20.00 | 21.00 | 19.00 | 19.00 | 15.00 | 15.00 | 13.00 | 17.00 | 15.00 |
Shareholder's Equity | 16.3% | 105 | 90.00 | 95.00 | 112 | 83.00 | 103 | 113 | 132 | 148 | 90.00 | 108 | 126 | 140 | 156 | 92.00 | 104 | 109 | 118 | 126 | 136 | - |
Retained Earnings | 3.9% | -354 | -369 | -344 | -325 | -307 | -287 | -275 | -257 | -240 | -222 | -201 | -181 | -164 | -147 | -134 | -121 | -113 | -103 | -92.80 | -81.39 | -69.31 |
Additional Paid-In Capital | -0.1% | 467 | 467 | 446 | 445 | 398 | 397 | 396 | 395 | 394 | 317 | 315 | 314 | 311 | 309 | 232 | 230 | 228 | 226 | 223 | 222 | 4.00 |
Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 26.00 | 26.00 | 26.00 | 18.00 | 15.00 | 10.00 | 1.00 |
Float | - | - | - | - | 72.00 | - | - | - | 83.00 | - | - | - | 238 | - | - | - | 207 | - | - | - | 101 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -115.2% | -24,156 | -11,224 | -24,119 | -19,333 | -2,848 | 13,137 | -16,508 | -18,359 | 1,733 | -13,243 | -17,644 | -20,732 | -14,397 | -11,301 | -10,365 | -10,545 | -7,128 | -8,793 | -9,485 | -11,397 | -12,056 |
Share Based Compensation | -159.7% | -249 | 417 | 574 | 696 | 658 | 1,001 | 1,040 | 1,381 | 1,621 | 1,777 | 1,719 | 2,627 | 1,521 | 2,265 | 2,147 | 2,151 | 2,094 | 2,104 | 1,872 | 1,206 | 383 |
Cashflow From Investing | 72.5% | -116 | -422 | -3,018 | -445 | -274 | -599 | -958 | -1,632 | -1,828 | -5,141 | -2,486 | -4,624 | -330 | -505 | -625 | -1,042 | -199 | -1,046 | -362 | -191 | -400 |
Cashflow From Financing | -100.6% | -135 | 21,249 | -659 | 45,815 | -735 | -196 | 127 | -2,953 | 75,293 | -410 | -11.00 | 85.00 | 101 | 75,076 | -222 | -150 | -1,284 | -883 | -532 | 76,009 | 35,157 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (UNAUDITED) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (UNAUDITED) | ||
Revenue from collaboration and licensing | $ 36,599 | $ 3,176 |
Revenue from Contract with Customer, Product and Service [Extensible List] | hook:CollaborationAndLicensingMember | hook:CollaborationAndLicensingMember |
Operating expenses: | ||
Research and development | $ (20,168) | $ (20,931) |
General and administrative | (4,056) | (4,902) |
Restructuring | (1,269) | |
Total operating expenses | (25,493) | (25,833) |
Income (loss) from operations | 11,106 | (22,657) |
Other income (expense): | ||
Grant income | 2,233 | 2,353 |
Interest income | 1,331 | 1,171 |
Interest expense | (2) | (122) |
Other income and (expenses), net | (285) | (220) |
Total other income, net | 3,277 | 3,182 |
Net income (loss) before tax | 14,383 | (19,475) |
Income tax expense | 0 | (205) |
Net income (loss) | 14,383 | (19,680) |
Other comprehensive (loss) income: | ||
Foreign currency translation gain (loss), net of tax | 531 | (17) |
Comprehensive income (loss) | $ 14,914 | $ (19,697) |
Net income (loss) per share - basic | $ 0.11 | $ (0.27) |
Net income (loss) per share - diluted | $ 0.11 | $ (0.27) |
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 92,751 | $ 117,096 |
Accounts receivable | 10,212 | 511 |
Receivable research incentives | 20,557 | 18,760 |
Prepaid expenses and other current assets | 9,190 | 10,749 |
Total current assets | 132,710 | 147,116 |
Non-current assets: | ||
Restricted cash | 204 | 425 |
Property, plant and equipment, net | 7,332 | 7,742 |
Operating lease right of use assets | 4,965 | 5,473 |
Other non-current assets | 660 | 581 |
Total non-current assets | 13,161 | 14,221 |
Total assets | 145,871 | 161,337 |
Current liabilities | ||
Accounts payable | 11,201 | 12,498 |
Deferred revenues | 4,649 | 14,631 |
Operating lease liabilities, current | 1,584 | 1,638 |
Accrued expenses and other current liabilities | 10,930 | 12,101 |
Loans payable, current | 1,144 | 1,120 |
Total current liabilities | 29,508 | 41,988 |
Non-current liabilities | ||
Operating lease liabilities, non-current | 3,354 | 3,801 |
Deferred revenues, non-current | 2,617 | 19,674 |
Other non-current liabilities | 5,870 | 6,017 |
Total non-current liabilities | 11,841 | 29,492 |
Total liabilities | 41,349 | 71,480 |
Commitments and contingencies (Note 13) | ||
Stockholders' equity: | ||
Preferred Stock | 0 | 0 |
Additional paid-in capital | 466,792 | 467,041 |
Accumulated other comprehensive loss | (7,402) | (7,933) |
Accumulated deficit | (354,878) | (369,261) |
Total stockholders' equity | 104,522 | 89,857 |
Total liabilities and stockholders' equity | 145,871 | 161,337 |
Common stock | ||
Stockholders' equity: | ||
Common stock | 10 | 10 |
Class A common stock | ||
Stockholders' equity: | ||
Common stock | $ 0 | $ 0 |